title: Management of early breast cancer--the current approach.
abstract: This seventh article in our series on breast disease will focus on what is new in the management of invasive primary breast cancer. Up-to-date information on the key aspects of breast cancer management is presented, including descriptions of the new technique of sentinel lymph node biopsy and the new hormone treatment, aromatase inhibitors. Current trends in surgery for breast cancer and the adjuvant treatments of chemotherapy and radiotherapy are also discussed.
authors.affiliation: NSW Breast Cancer Institute, Westmead Hospital, New South Wales, Australia. meaganb@bci.org.au
authors.forename: Meagan
authors.initials: M
authors.lastname: Brennan
authors.forename: Nicholas
authors.initials: N
authors.lastname: Wilcken
authors.forename: James
authors.initials: J
authors.lastname: French
authors.forename: Owen
authors.initials: O
authors.lastname: Ung
authors.forename: John
authors.initials: J
authors.lastname: Boyages
mesh_terms: D047072:Aromatase Inhibitors / Q000627:therapeutic use; D001365:Axilla; D001943:Breast Neoplasms / Q000473:pathology / Q000628:therapy*; D017024:Chemotherapy, Adjuvant / Q000379:methods; D005260:Female; D006694:Holistic Health; D006801:Humans; D008197:Lymph Node Excision / Q000379:methods; D008408:Mastectomy / Q000379:methods; D009364:Neoplasm Recurrence, Local; D010348:Patient Care Team / Q000458:organization & administration; D018714:Radiotherapy, Adjuvant / Q000379:methods; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D013629:Tamoxifen / Q000627:therapeutic use
chemical_list: D047072:Aromatase Inhibitors; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen